The increasing complexity of drug products brings pharmaceutical companies significant manufacturing challenges arising from the pandemic. This includes disrupting supply...
Curia, the US CDMO formerly known as AMRI, has announced it will invest $35 million to expand commercial manufacturing capacity at its Rensselaer, New York, production...
Alex Gorsky, chairman and CEO of Johnson & Johnson since 2012, has announced he will step down from the healthcare giant’s top slot at the beginning of 2022 and hand over...
Dow is investing an undisclosed sum in its methyl acrylate production to meet growing demand both in North America and worldwide. The project at its St Charles operations...
US drugmaker Eli Lilly has announced changes to its executive leadership team as it creates two new business units in order to strengthen its focus on introducing...
After more than a decade, the US Environmental Protection Agency (EPA) is finally moving to block the use of the controversial insecticide active ingredient chorpyrifos...
US biotech Novavax, in the final stage of developing its protein-based Covid-19 vaccine, NVX-CoV2373, is adding muscle in human resources before applying to the US Food...
Ineos Energy, Wintershall Dea and a consortium of 29 companies, research institutes and universities have signed an agreement to support the next and second phase of the...
Despite the double whammy of the coronavirus pandemic and the related supply chain disruption, Germany’s chemical and pharmaceutical industries performed well in the...
UK sustainable technologies company Johnson Matthey and Kebobtix, a US technology platform company for new chemicals and materials, have agreed to jointly explore...
